Dr Julian Rm Mendoza, MD | |
121 W 23rd St, Anderson, IN 46016-4325 | |
(765) 642-8989 | |
(765) 649-1341 |
Full Name | Dr Julian Rm Mendoza |
---|---|
Gender | Male |
Speciality | Urology |
Location | 121 W 23rd St, Anderson, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1861497356 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 01033405 (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Julian Rm Mendoza, MD 121 W 23rd St, Anderson, IN 46016-4325 Ph: (765) 642-8989 | Dr Julian Rm Mendoza, MD 121 W 23rd St, Anderson, IN 46016-4325 Ph: (765) 642-8989 |
News Archive
Pfizer Inc. announced today its investigational compound palbociclib (PD-0332991), an oral and selective inhibitor of cyclin dependent kinases (CDK) 4 and 6, has received Breakthrough Therapy designation by the United States Food and Drug Administration for the potential treatment of patients with breast cancer.
A team of researchers at the University of Cincinnati College of Medicine have been awarded $3.4 million by the National Institutes of Health to study the role of the gastrointestinal lymphatic system in dietary nutrient absorption and the transport of signaling molecules.
For discoveries about how the brain calculates and remembers where it is—which could be part of the foundation of memory—Columbia University will award the 2013 Louisa Gross Horwitz Prize to Edvard I. Moser, PhD, and May-Britt Moser, PhD, of the Norwegian University of Science and Technology in Norway, and John Michael O'Keefe, PhD, of University College London in the UK.
Mice exposed to low doses of arsenic in drinking water, similar to what some people might consume, developed lung cancer, researchers at the National Institutes of Health have found.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to hGH-CTP, PROLOR's longer-acting version of human growth hormone for the treatment of growth hormone deficiency.
› Verified 5 days ago
Dr. Lawrence Edward Allen, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 854 Ashbrooke Ct, Anderson, IN 46012 Phone: 765-642-7702 | |
Salah Elsaharty, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1210 Medical Arts Blvd, Suite 104, Anderson, IN 46011 Phone: 765-298-4198 |